Idifarma announces new Director of Operations

Daniel Rivero will join the Spanish CDMO from 3P Biopharmaceuticals

Daniel Rivero, New Director or Operations

Idifarma, a Spanish CDMO specialising in niche and highly potent products, has appointed of Daniel Rivero as its Director of Operations.

Rivero will be responsible for the planning and scheduling of all client projects, ensuring the company achieves high productivity levels and delivers on its promises to produce high quality and cost-effective drug products. Rivero will also assure compliance across all legal, quality, human and environmental regulations for Idifarma and its customers.

With over 15 years’ experience in strategic operations within the pharmaceutical industry, Rivero joins the company from his most recent position at 3P Biopharmaceuticals, where he was Plant Director for almost a decade.

Luis Oquiñena, General Manager and Co-founder of Idifarma, said: “We are really pleased to have Daniel onboard as part of our growing leadership team. He brings a wealth of expertise that will support Idifarma in delivering operational excellence and high-quality standards for our customers.

“Following a period of rapid growth and with an expanding client portfolio, strengthening our senior leadership team is a natural next step as Idifarma develops in the market,” Oquiñena added.

Commenting on his new role Rivero said: “I am excited to be joining Idifarma at such a pivotal time, as we expand into new markets and look to become more aligned with regulatory agencies across the globe.

Companies